Target intelligence / Profile preview

SLAM family member 6 pseudogene 1 (SLAMF6P1)

Target
SLAMF6P1
Molecular classification
Other (Pseudogene)
01

Overview

SLAM family member 6 pseudogene 1 (SLAMF6P1) is classified as a pseudogene and thus is generally considered non-protein-coding[1][5]. Pseudogenes are genomic elements related to protein-coding genes but have lost their protein-coding potential due to mutations or truncations. While some pseudogenes have been implicated in regulation of biological processes through noncoding RNA or by acting as microRNA decoys, there is no evidence that SLAMF6P1 has such roles. Unlike its parent gene SLAMF6, which encodes a cell surface immune receptor with regulatory functions in T cell activity, SLAMF6P1 is not known to encode any functional protein or receptor and is not a therapeutic target[1][3][5]. SLAMF6P1 is not a functional receptor, enzyme, or therapeutic target, but a pseudogene; thus, it should not be classified as a drug target or biomarker. The only functional molecule in this family relevant for drug targeting and disease is SLAM family member 6 (SLAMF6 or CD352), not SLAMF6P1[1][5].

02

Mechanism of action

None (no evidence of drug targeting or intrinsic activity)

03

Biological functions

Pseudogenes may participate in gene regulation at the RNA level, including acting as microRNA decoys or producing noncoding RNA that can influence expression of functional genesThere is no evidence SLAMF6P1 itself has a defined biological function.
04

Disease associations

None established for SLAMF6P1 specificallyhowever, some pseudogenes can be deregulated in cancer or play regulatory roles

Beyond the preview

Go deeper on SLAM family member 6 pseudogene 1 (SLAMF6P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SLAM family member 6 pseudogene 1 (SLAMF6P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call